Fibonacci has lost it, totally! So has watsonhelpe
Post# of 30028
Perhaps he is suggesting that we might not get the multivariant results for a few weeks after that. Maybe, but that won't stop our progress commercializing.
Besides, multivariant data is not as important as we used to think. We used to think that Big Pharma doing thousands of tests during clinical trails were willing to test all 6 univariant bio-markets and do the math necessary to get multivariant scores in the 90s. They aren't that excited about that. They are according to Gerald very pleased with the ease of Lympro univariant CD 19 and it's 80% accuracy on a stand alone basis! And it's cheapness!
Fibonacci is just bashing.